Veeva Systems Reports 16% Revenue Growth in Q4 2025, Driven by System Modernization and AI Initiatives
Veeva Systems reported Q4 CY2025 sales of $836 million, a 16% increase year-on-year. Guidance for next quarter's revenue is $856.5 million, exceeding analyst expectations. The company's non-GAAP profit was $2.06 per share, surpassing estimates by 6.5%. Key growth drivers included demand for legacy system modernization and expansion among top pharmaceutical companies. Management highlighted the importance of automation in core systems and noted growing interest in AI-driven solutions for compliance and workflow efficiency.
Theia Market Signal Identification - AI Assisted
Veeva Systems achieved Q4 CY2025 sales of $836 million, marking a 16% year-on-year increase. The revenue guidance for the next quarter stands at $856.5 million, exceeding analyst expectations. Non-GAAP profit per share was $2.06, 6.5% above consensus estimates.
The company experienced strong demand for modernizing legacy systems, particularly from top pharmaceutical firms, emphasizing the need for scalable solutions. Management noted a focus on AI-driven automation and integration into existing platforms, with expectations for growth in R&D and safety solutions. Veeva aims to leverage contract research organizations to enhance sales opportunities with emerging biotech customers.
Comments